We can therefore hypothesize that Cav1 expression is dramatically reduced in metastatic tissue as compared to primary tumour, as reported by Zhang et al. [22], but that this downregulation is also a hallmark of metastasis-prone HNSCC before extension to distant sites. The gene discussed is CAV1; the disease is head and neck squamous cell carcinoma.